Drug Delivery

Approach Shows Promise for Delivering Thrombolytic Drug

Published in Blood Weekly, March 30th, 2000

A novel approach may improve the delivery of enzyme drugs, according to researchers in the United States.

J.F. Liang and colleagues reported on their attempts in improving thrombolytic drug delivery in a study titled "A novel delivery system for tissue plasminogen activator," at a meeting of the American Association of Pharmaceutical Scientists in New Orleans, Louisiana, USA.

Major reasons for the lack of clinical applications of enzyme lie in the potential immunogenicity, as well as the indiscriminate nature of an enzyme in its action towards both target and normal substrate, they noted.

Liang et al. developed in their laboratory...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-03-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry